Cargando…

Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation

Stimulating the immune system to attack cancer is a promising approach, even for the control of advanced cancers. Several cytokines that promote interferon-γ-dominated immune responses show antitumor activity, with interleukin 12 (IL-12) being of major importance. Here, we used an antibody-IL-12 fus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schilbach, Karin, Alkhaled, Mohammed, Welker, Christian, Eckert, Franziska, Blank, Gregor, Ziegler, Hendrik, Sterk, Marco, Müller, Friederike, Sonntag, Katja, Wieder, Thomas, Braumüller, Heidi, Schmitt, Julia, Eyrich, Matthias, Schleicher, Sabine, Seitz, Christian, Erbacher, Annika, Pichler, Bernd J, Müller, Hartmut, Tighe, Robert, Lim, Annick, Gillies, Stephen D, Strittmatter, Wolfgang, Röcken, Martin, Handgretinger, Rupert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485786/ https://www.ncbi.nlm.nih.gov/pubmed/26140238 http://dx.doi.org/10.1080/2162402X.2015.1014760

Ejemplares similares

Human Peripheral CD4(+) Vδ1(+) γδT Cells Can Develop into αβT Cells
por: Ziegler, Hendrik, et al.
Publicado: (2014)

Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma
por: Tenente, Inês M, et al.
Publicado: (2017)

In the Absence of a TCR Signal IL-2/IL-12/18-Stimulated γδ T Cells Demonstrate Potent Anti-Tumoral Function Through Direct Killing and Senescence Induction in Cancer Cells
por: Schilbach, Karin, et al.
Publicado: (2020)

Chorein addiction in VPS13A overexpressing rhabdomyosarcoma cells
por: Honisch, Sabina, et al.
Publicado: (2015)

Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report
por: Sonntag, Katja, et al.
Publicado: (2018)

BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma
por: Laubscher, Dominik, et al.
Publicado: (2021)

SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state
por: Hsu, Jessica Y., et al.
Publicado: (2022)

Exon skipping in genes encoding lineage-defining myogenic transcription factors in rhabdomyosarcoma
por: Butler, Erin, et al.
Publicado: (2022)

Differentiation-dependent chromosomal organization changes in normal myogenic cells are absent in rhabdomyosarcoma cells
por: Ibarra, Joe, et al.
Publicado: (2023)

Differentiation-dependent chromosomal organization changes in normal myogenic cells are absent in rhabdomyosarcoma cells
por: Ibarra, Joe, et al.
Publicado: (2023)

PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors
por: Searcy, Madeline B., et al.
Publicado: (2023)

Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.
por: Nicoletti, G., et al.
Publicado: (1992)

Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression
por: Skrzypek, Klaudia, et al.
Publicado: (2015)

PROX1 transcription factor controls rhabdomyosarcoma growth, stemness, myogenic properties and therapeutic targets
por: Gizaw, Nebeyu Yosef, et al.
Publicado: (2022)

Combined application of arsenic trioxide and lithium chloride augments viability reduction and apoptosis induction in human rhabdomyosarcoma cell lines
por: Schleicher, Sabine B., et al.
Publicado: (2017)

Restoration of p16(INK4A) protein induces myogenic differentiation in RD rhabdomyosarcoma cells
por: Urashima, M, et al.
Publicado: (1999)

Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol
por: Koscielniak, Ewa, et al.
Publicado: (2022)

Removal of CD276(+) cells from haploidentical memory T-cell grafts significantly lowers the risk of GVHD
por: Hashimoto, Hisayoshi, et al.
Publicado: (2021)

Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells
por: Wolff, David W., et al.
Publicado: (2018)

GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells
por: Seitz, Christian M., et al.
Publicado: (2019)

Cytokine-Induced Senescence in the Tumor Microenvironment and Its Effects on Anti-Tumor Immune Responses
por: Rentschler, Maximilian, et al.
Publicado: (2022)

Retinoic acid induces myogenin synthesis and myogenic differentiation in the rat rhabdomyosarcoma cell line BA-Han-1C
Publicado: (1992)

Modulation of Myogenic Differentiation in a Human Rhabdomyosarcoma Cell Line by a New Derivative of 5‐Fluorouracil (QF‐3602)
por: Marchal, Juan Antonio, et al.
Publicado: (2000)

Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins
por: Gerhart, Jacquelyn, et al.
Publicado: (2019)

Upregulation of miR181a/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma
por: Pozzo, Enrico, et al.
Publicado: (2021)

Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile
por: Schleicher, Sabine, et al.
Publicado: (2020)

JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
por: Walters, Zoë S, et al.
Publicado: (2013)

Epitope Detection in Monocytes (EDIM) As a New Method of Liquid Biopsy in Pediatric Rhabdomyosarcoma
por: Urla, Cristian, et al.
Publicado: (2022)

D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma
por: Urla, Cristian, et al.
Publicado: (2022)

Anti-oncogenic and pro-myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma
por: Di Rocco, Agnese, et al.
Publicado: (2022)

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Döring, Michaela, et al.
Publicado: (2012)

DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation
por: Megiorni, Francesca, et al.
Publicado: (2016)

Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo
por: Giralt, Irina, et al.
Publicado: (2021)

The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
por: Braumüller, Heidi, et al.
Publicado: (2022)

T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment
por: Zheng, Ziwen, et al.
Publicado: (2023)

MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line
por: Faggi, Fiorella, et al.
Publicado: (2015)

Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
por: Megiorni, Francesca, et al.
Publicado: (2017)

Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma
por: Kanayama, Takuyo, et al.
Publicado: (2021)

Enhancement of myogenic differentiation and inhibition of rhabdomyosarcoma progression by miR-28-3p and miR-193a-5p regulated by SNAIL
por: Skrzypek, Klaudia, et al.
Publicado: (2021)

The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines
por: Schmidt, Andreas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a0b8fvfode2va8tls8juo3nmoo